Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma

[1]  M. Urken,et al.  Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus? , 2017, Thyroid : official journal of the American Thyroid Association.

[2]  R. Lloyd,et al.  Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review , 2017, Endocrine Pathology.

[3]  C. Solórzano,et al.  Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy? , 2017, Journal of the American College of Surgeons.

[4]  R. Celestino,et al.  Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases , 2017, The American journal of surgical pathology.

[5]  L. Mazzucchelli,et al.  Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review , 2017, Cancer cytopathology.

[6]  S. Chuai,et al.  Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma , 2017, Oncotarget.

[7]  A. Sapino,et al.  Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. , 2017, Endocrine-related cancer.

[8]  Tao Zhang,et al.  Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality , 2017, JAMA oncology.

[9]  J. Fagin,et al.  Biologic and Clinical Perspectives on Thyroid Cancer. , 2016, The New England journal of medicine.

[10]  Xiaofei Wang,et al.  Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology , 2016, Oncotarget.

[11]  I. Ganly,et al.  Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. , 2015, Human pathology.

[12]  Z. Baloch,et al.  PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma , 2015, Endocrine Pathology.

[13]  H. Moch,et al.  Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. , 2015, Endocrine-related cancer.

[14]  T. Meitinger,et al.  A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors , 2015, BMC Cancer.

[15]  S. El-Mofty,et al.  Prevalence of a Hobnail Pattern in Papillary, Poorly Differentiated, and Anaplastic Thyroid Carcinoma: A Possible Manifestation of High-grade Transformation , 2015, The American journal of surgical pathology.

[16]  Steven J. M. Jones,et al.  MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma. , 2015, The Journal of clinical endocrinology and metabolism.

[17]  N. Besic,et al.  Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience , 2014, BMC Cancer.

[18]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[19]  D. Dias-Santagata,et al.  Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. , 2014, Thyroid : official journal of the American Thyroid Association.

[20]  Woo Jin Oh,et al.  Classic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features , 2014, Korean journal of pathology.

[21]  RiveraMichael,et al.  Prognostic implications of papillary thyroid carcinoma with tall-cell features. , 2014 .

[22]  T. Fahey,et al.  Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma. , 2013, Surgery.

[23]  E. Kaplan,et al.  A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. , 2013, Surgery.

[24]  J. Bishop,et al.  Highly prevalent TERT promoter mutations in aggressive thyroid cancers. , 2013, Endocrine-related cancer.

[25]  T. Chan,et al.  Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. , 2013, The Journal of clinical endocrinology and metabolism.

[26]  V. Nosé,et al.  Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression. , 2013, Thyroid : official journal of the American Thyroid Association.

[27]  T. Uruno,et al.  Does Hürthle Cell Carcinoma of the Thyroid Have a Poorer Prognosis than Ordinary Follicular Thyroid Carcinoma? , 2013, Annals of Surgical Oncology.

[28]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[29]  R. Lloyd,et al.  Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. , 2013, Human pathology.

[30]  S. Roman,et al.  Hurthle cell carcinoma , 2013, Cancer.

[31]  J. Bishop,et al.  Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. , 2012, Thyroid : official journal of the American Thyroid Association.

[32]  S. Roman,et al.  Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients , 2012, Annals of Surgical Oncology.

[33]  Z. Baloch,et al.  CDX2 expression in columnar cell variant of papillary thyroid carcinoma. , 2012, American journal of clinical pathology.

[34]  S. Asa,et al.  Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation , 2011, Modern Pathology.

[35]  Rajni Sharma,et al.  PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. , 2011, Human pathology.

[36]  Z. Baloch,et al.  The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[37]  R. Lloyd,et al.  Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma , 2011, Modern Pathology.

[38]  C. O'Neill,et al.  Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  I. Ganly,et al.  Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. , 2010, Thyroid : official journal of the American Thyroid Association.

[40]  R. Lloyd,et al.  Papillary Thyroid Carcinoma With Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma. A Clinicopathologic, Immunohistochemical, and Molecular Study of Eight Cases , 2010, The American journal of surgical pathology.

[41]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[42]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[43]  V. Livolsi,et al.  Papillary thyroid carcinoma tall cell variant. , 2008, Thyroid : official journal of the American Thyroid Association.

[44]  S. Larson,et al.  Histopathologic characterization of radioactive iodine‐refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinoma , 2008, Cancer.

[45]  M. Hirokawa,et al.  Prevalence and Prognostic Significance of Poor Differentiation and Tall Cell Variant in Papillary Carcinoma in Japan , 2008, World Journal of Surgery.

[46]  M. Rivera,et al.  Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. , 2007, Thyroid : official journal of the American Thyroid Association.

[47]  Bhuvanesh Singh,et al.  Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. , 2006, Surgery.

[48]  J. Shah,et al.  Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland , 2006, Cancer.

[49]  T. Giordano,et al.  Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas , 2006, The American journal of surgical pathology.

[50]  D. Urbach,et al.  The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. , 2005, Surgery.

[51]  Dillwyn Williams,et al.  Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid , 2005, British Journal of Cancer.

[52]  Q. Duh,et al.  Follicular thyroid carcinoma: Histology and prognosis , 2004, Cancer.

[53]  N. Ordóñez,et al.  Prognostic factors in patients with Hürthle cell neoplasms of the thyroid , 2003, Cancer.

[54]  P. Soares,et al.  Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. , 2002, The American journal of pathology.

[55]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[56]  B. Wenig,et al.  Thyroid papillary carcinoma of columnar cell type , 1998, Cancer.

[57]  G. Tomlinson,et al.  Prognostic Features in Tall Cell Papillary Carcinoma and Insular Thyroid Carcinoma , 1997, The Laryngoscope.

[58]  R. Lloyd,et al.  Columnar cell carcinoma of the thyroid: report of three additional cases. , 1996, Human pathology.

[59]  H. Evans.  Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. , 1996, The American journal of surgical pathology.

[60]  H. Hundeshagen,et al.  Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings , 1986, The American journal of surgical pathology.

[61]  N. Samaan,et al.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. , 1983, The Journal of clinical endocrinology and metabolism.

[62]  R W Raven,et al.  The british association of surgical oncology , 1973, Annals of the Royal College of Surgeons of England.

[63]  S. Barollo,et al.  The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes. , 2018, Thyroid : official journal of the American Thyroid Association.

[64]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[65]  B. Necela,et al.  Clinical and molecular features of Hürthle cell carcinoma of the thyroid. , 2015, The Journal of clinical endocrinology and metabolism.

[66]  J. Shah,et al.  Prognostic implications of papillary thyroid carcinoma with tall-cell features. , 2014, Thyroid : official journal of the American Thyroid Association.

[67]  M. Hirokawa,et al.  Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. , 2013, Endocrine journal.

[68]  R. Seethala.  Histopathologic Characterization of Radioactive Iodine-refractory Fluorodeoxyglucose-Positron Emission Tomography-positive Thyroid Carcinoma , 2009 .

[69]  B. Wenig,et al.  Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. , 1998, Cancer.

[70]  H. Evans.  Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. , 1986, American journal of clinical pathology.

[71]  Lippincott Williams Wilkins,et al.  The American journal of surgical pathology , 1977 .

[72]  Hawk Wa,et al.  The many appearances of papillary carcinoma of the thyroid. , 1976 .

[73]  J. Hazard,et al.  The many appearances of papillary carcinoma of the thyroid. , 1976, Cleveland Clinic quarterly.